SENSEX
NIFTY
GOLD
USD/INR

Weather

image 23    C

Opinion News

The Economic Times

Opinion / The Economic Times

details

The promise of EU-India FTA for Indian patients: A case for price regulation

The EU-India FTA promises cheaper drugs and medical devices, but India's regulatory framework may hinder patient benefits. Current pricing mechanisms, including market-based ceiling prices and loopholes for fixed-dose combinations, prevent cost reductions from reflecting in retail prices. An urgent overhaul of drug pricing and an independent regulator for procedures are needed to ensure affordability and realize the FTA's full potential.

24 Feb 2026 10:28 am